Medicare Enrolled
Dr. Sanyasi Ganta, M.D,
Family Medicine · Hemet, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ganta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ganta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ganta
Dr. Sanyasi Ganta is a family medicine specialist in Hemet, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ganta performed 1,308 Medicare services across 503 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ganta received a total of $20,760 from 91 pharmaceutical and/or device companies across 1324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ganta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in CA
$20,760 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,308
Medicare services
Top 17% in CA for family medicine
503
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~69 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
687 | $81 | $165 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
245 | $92 | $140 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
129 | $27 | $75 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
57 | $130 | $250 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
56 | $62 | $140 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
43 | $91 | $133 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 38 | $20 | $35 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
38 | $24 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $66 | $165 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,760
Total received (2018-2024)
Avg $2,966/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
91
Companies
1,324
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,748 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,203
2023
$3,514
2022
$2,815
2021
$3,614
2020
$2,284
2019
$2,176
2018
$3,153
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$529
Neurocrine Biosciences, Inc.
$321
Boehringer Ingelheim Pharmaceuticals, Inc.
$203
Novartis Pharmaceuticals Corporation
$195
ABBVIE INC.
$190
Amgen Inc.
$188
GlaxoSmithKline, LLC.
$175
Teva Pharmaceuticals USA, Inc.
$173
Bayer Healthcare Pharmaceuticals Inc.
$151
Sumitomo Pharma America, Inc.
$133
Lilly USA, LLC
$102
SHIELD THERAPEUTICS INC
$99
Abbott Laboratories
$91
Novo Nordisk Inc
$85
Ardelyx, Inc.
$69
Dexcom, Inc.
$63
GENZYME CORPORATION
$54
Eisai Inc.
$50
SCILEX PHARMACEUTICALS INC.
$42
Janssen Pharmaceuticals, Inc
$41
EVOKE PHARMA, INC.
$41
PFIZER INC.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
Baxter Healthcare
$31
E.R. Squibb & Sons, L.L.C.
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
Merck Sharp & Dohme LLC
$22
Paratek Pharmaceuticals, Inc.
$17
CeQur Corporation
$15
Otsuka America Pharmaceutical, Inc.
$14
Top 3 companies account for 32.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,674
GlaxoSmithKline, LLC.
$1,177
Janssen Pharmaceuticals, Inc
$1,076
Boehringer Ingelheim Pharmaceuticals, Inc.
$989
Amgen Inc.
$939
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$886
ABBVIE INC.
$839
Novo Nordisk Inc
$832
AbbVie Inc.
$825
Neurocrine Biosciences, Inc.
$787
Novartis Pharmaceuticals Corporation
$639
Lilly USA, LLC
$586
PFIZER INC.
$531
UCB, Inc.
$484
Teva Pharmaceuticals USA, Inc.
$477
Allergan Inc.
$413
Allergan, Inc.
$411
Astellas Pharma US Inc
$378
Corcept Therapeutics
$359
Bayer Healthcare Pharmaceuticals Inc.
$353
Merck Sharp & Dohme Corporation
$309
Merck Sharp & Dohme LLC
$283
Eisai Inc.
$273
Bayer HealthCare Pharmaceuticals Inc.
$256
Abbott Laboratories
$250
Biohaven Pharmaceuticals, Inc.
$228
Sunovion Pharmaceuticals Inc.
$218
Amarin Pharma Inc.
$211
MannKind Corporation
$188
SANOFI-AVENTIS U.S. LLC
$180
Sumitomo Pharma America, Inc.
$157
E.R. Squibb & Sons, L.L.C.
$153
Avanir Pharmaceuticals, Inc.
$144
Dexcom, Inc.
$141
AbbVie, Inc.
$138
SHIELD THERAPEUTICS INC
$99
Takeda Pharmaceuticals U.S.A., Inc.
$98
Circassia Pharmaceuticals Inc
$88
Neurelis, Inc.
$85
Mannkind Corporation
$81
Scilex Pharmaceuticals Inc.
$79
Esperion Therapeutics, Inc.
$78
Lundbeck LLC
$73
Ardelyx, Inc.
$69
Otsuka America Pharmaceutical, Inc.
$55
GENZYME CORPORATION
$54
Medtronic, Inc.
$48
Gilead Sciences, Inc.
$47
Biogen, Inc.
$44
SCILEX PHARMACEUTICALS INC.
$42
EVOKE PHARMA, INC.
$41
IDORSIA PHARMACEUTICALS US INC
$41
ARBOR PHARMACEUTICALS, INC.
$40
DEXCOM, INC.
$40
SANOFI PASTEUR INC.
$36
CMP Pharma, Inc.
$33
CeQur Corporation
$33
Baxter Healthcare
$31
Medtronic MiniMed, Inc.
$28
Valeritas, Inc.
$26
Corium, LLC
$26
SK Life Science, Inc.
$26
Antares Pharma, Inc.
$25
Kyowa Kirin, Inc.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Nestle HealthCare Nutrition Inc.
$24
Radius Health, Inc.
$24
Kowa Pharmaceuticals America, Inc.
$23
Mylan Specialty L.P.
$23
Ironwood Pharmaceuticals, Inc
$23
Melinta Therapeutics, Inc.
$22
EISAI INC.
$21
Azurity Pharmaceuticals, Inc.
$21
Alkermes, Inc.
$21
Arbor Pharmaceuticals, Inc.
$20
Exact Sciences Corporation
$19
Amneal Pharmaceuticals LLC
$19
Insulet Corporation
$18
Biohaven Pharmaceutical Holding Company Ltd.
$18
Paratek Pharmaceuticals, Inc.
$17
Vertical Pharmaceuticals, LLC
$17
Xeris Pharmaceuticals, Inc.
$16
Sanofi Pasteur Inc.
$15
Sun Pharmaceutical Industries Inc.
$15
Lucid Diagnostics Inc.
$14
Smith & Nephew, Inc.
$14
Virtus Pharmaceuticals LLC
$12
ACADIA Pharmaceuticals Inc
$12
Nevro Corp.
$12
Genentech USA, Inc.
$12
Novum Pharma, LLC
$11
Top 3 companies account for 23.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADUHELM · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ARISTADA · AUSTEDO · AVYCAZ · Adlarity · Aimovig · Alcortin A · Amitiza · Austedo XR · BAQSIMI · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYDUREON · BYSTOLIC · Baxdela · Belviq · Briviact · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Carospir · CeQur Simplicity · Coblation - Tonsil Wands · Colcrys · Cologuard Collection Kit · Creon · DALVANCE · DEXCOM G6 TRANSMITTER · DIFICID · DUAKLIR PRESSAIR · DUPIXENT · DUZALLO · Dayvigo · Dexcom CGM · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fintepla · FreeStyle Libre · GATTEX · GEMTESA · GIMOTI · GUARDIAN SENSOR (3) · GVOKE PFS · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Horizant · IBSRELA · INGREZZA · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · Infinity DBS Pulse Generators · JANUVIA · JARDIANCE · KAPSPARGO · KYNMOBI · Kerendia · Korlym · LEQVIO · LEVORPHANOL TARTRATE · LINZESS · LOKELMA · LONHALA MAGNAIR · LUCEMYRA · LYRICA · Leqembi · Livalo · MOUNJARO · MYFEMBREE · MYRBETRIQ · Minimed 670G System · Myrbetriq · NEXLETOL · NUCALA · NUEDEXTA · NUPLAZID · NURTEC ODT · NUZYRA · ONGENTYS · OSMOLEX ER · OXBRYTA · Omnia · Omnipod · Ongentys · Otezla · Ozempic · PREMARIN · Perforomist · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · RIOMET ER · RYBELSUS · RYTARY · Rybelsus · SEEBRI · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · TEFLARO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Tymlos · UBRELVY · UTIBRON · Utibron · V-GO · VALTOCO · VERQUVO · VESICARE · VIBERZI · VRAYLAR · Vascepa · Victoza · Vimpat · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · ZENPEP · ZEPBOUND · ZINPLAVA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
350
Per 100K population
14.3
County median income
$89,672
Nearest hospital
HEMET GLOBAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ganta is a clinical cardiology specialist, with above-average Medicare volume (top 17% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ganta experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ganta performed 687 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ganta receive payments from pharmaceutical companies?
Yes. Dr. Ganta received a total of $20,760 from 91 companies across 1,324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ganta's costs compare to other family medicine physicians in Hemet?
Dr. Ganta's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ganta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Hemet
Browse family medicine physicians in Hemet ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology